---
figid: PMC2614304__nihms-79970-f0006
figlink: /pmc/articles/PMC2614304/figure/F6/
number: F6
caption: PKCα phosphorylates Bcl-2 at serine 70, preventing Bcl-2 from degradation.
  Treatment with cisplatin produces PKCα dephosphorylation or inactivation, which
  decreases the levels of phosphorylation of Bcl-2. The ubiquitin/proteasome pathway
  degrades dephosphorylated Bcl-2. Once the levels of Bcl-2 decrease, the pro-apoptotic
  protein BAX is released activating the apoptotic pathway. The expression of mt-PCPH
  prevents cisplatin-induced PKCα dephosphorylation. Activated PKCα prevents Bcl-2
  degradation. High levels of Bcl-2 protect prostate cancer cells against apoptosis
  induced by cisplatin.
pmcid: PMC2614304
papertitle: PCPH/ENTPD5 expression confers to prostate cancer cells resistance against
  cisplatin-induced apoptosis through PKCα-mediated Bcl-2 stabilization.
reftext: Joaquín Villar, et al. Cancer Res. ;69(1):102-110.
pmc_ranked_result_index: '64288'
pathway_score: 0.8473764
filename: nihms-79970-f0006.jpg
figtitle: PCPH/ENTPD5 expression confers to prostate cancer cells resistance against
  cisplatin-induced apoptosis through PKCAlpha-mediated Bcl-2 stabilization
year: ''
organisms: Homo sapiens
ndex: afebfc9a-deb0-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2614304__nihms-79970-f0006.html
  '@type': Dataset
  description: PKCα phosphorylates Bcl-2 at serine 70, preventing Bcl-2 from degradation.
    Treatment with cisplatin produces PKCα dephosphorylation or inactivation, which
    decreases the levels of phosphorylation of Bcl-2. The ubiquitin/proteasome pathway
    degrades dephosphorylated Bcl-2. Once the levels of Bcl-2 decrease, the pro-apoptotic
    protein BAX is released activating the apoptotic pathway. The expression of mt-PCPH
    prevents cisplatin-induced PKCα dephosphorylation. Activated PKCα prevents Bcl-2
    degradation. High levels of Bcl-2 protect prostate cancer cells against apoptosis
    induced by cisplatin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCA
  - CASP9
  - CASP1
  - CASP2
  - CASP14
  - CASP10
  - CASP4
  - CASP5
  - CASP6
  - ENTPD5
  - CASP8
  - BCL2
  - CASP12
  - CASP3
  - CASP7
  - Cisplatin
genes:
- word: PKCA
  symbol: PKCA
  source: hgnc_prev_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: PCPH/
  symbol: PCPH
  source: hgnc_prev_symbol
  hgnc_symbol: ENTPD5
  entrez: '957'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
chemicals:
- word: Cisplatin
  source: MESH
  identifier: D002945
diseases: []
figid_alias: PMC2614304__F6
redirect_from: /figures/PMC2614304__F6
figtype: Figure
---
